Compile Data Set for Download or QSAR
Report error Found 212 for UniProtKB: Q9UL62
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50601265(CHEMBL5177160)
Affinity DataEC50:  480nMAssay Description:Agonist activity at human TRPC5 stably expressed in T-REx-293 cells assessed as increase in calcium flux by Fura-2AM dye based fluorescence plate rea...More data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50601266(CHEMBL5173479)
Affinity DataEC50:  1.25E+3nMAssay Description:Agonist activity at human TRPC5 stably expressed in T-REx-293 cells assessed as increase in calcium flux by Fura-2AM dye based fluorescence plate rea...More data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50601267(ENGLERIN A | CHEBI:72441 | Englerin A)
Affinity DataEC50:  7.60nMAssay Description:Agonist activity at human TRPC5 stably expressed in HEK293 cells assessed as increase in calcium flux by Fura-2AM dye based fluorescence plate reader...More data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetShort transient receptor potential channel 1/5(Human)
University of Nebraska Medical Center

Curated by ChEMBL
LigandPNGBDBM50519465(CHEMBL4466522)
Affinity DataIC50: 0.190nMAssay Description:Inhibition of human TRPC5/human TRPC1 expressed in HEK293 cells assessed as reduction in englerin A-induced calcium entry incubated for 30 mins by Fl...More data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50519473(CHEMBL4546097)
Affinity DataIC50: 0.520nMAssay Description:Inhibition of human TRPC5 expressed in human T-REx-293 cells assessed as reduction in lanthanum-activated TRPC5-mediated currents by whole-cell patch...More data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM246445(US9447114, 1)
Affinity DataIC50: 1nMpH: 7.2Assay Description:TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM246446(US9447114, 2)
Affinity DataIC50: 1nMpH: 7.2Assay Description:TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM246465(US9447114, 26)
Affinity DataIC50: 1nMpH: 7.2Assay Description:TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM246466(US9447114, 27)
Affinity DataIC50: 1nMpH: 7.2Assay Description:TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50532608(CHEMBL4525688)
Affinity DataIC50: 1nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50532608(CHEMBL4525688)
Affinity DataIC50: 1nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50532612(CHEMBL4459054)
Affinity DataIC50: 1nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as reduction of rise in intracellular Ca2+ concentration after 60 to 8...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50532612(CHEMBL4459054)
Affinity DataIC50: 1nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as reduction of rise in intracellular Ca2+ concentration after 60 to 8...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50532612(CHEMBL4459054)
Affinity DataIC50: 1nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50532612(CHEMBL4459054)
Affinity DataIC50: 1nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50519465(CHEMBL4466522)
Affinity DataIC50: 1.30nMAssay Description:Inhibition of human TRPC5 expressed in HEK293 cells assessed as reduction in englerin A-induced calcium entry incubated for 30 mins by Fluo-4AM dye b...More data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM246463(US9447114, 24)
Affinity DataIC50: 1.84nMpH: 7.2Assay Description:TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM246465(US9447114, 26)
Affinity DataIC50: 1.91nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50532609(CHEMBL4466158)
Affinity DataIC50: 2.60nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as reduction of rise in intracellular Ca2+ concentration after 60 to 8...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50532609(CHEMBL4466158)
Affinity DataIC50: 2.60nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as reduction of rise in intracellular Ca2+ concentration after 60 to 8...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50532608(CHEMBL4525688)
Affinity DataIC50: 2.70nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as reduction of rise in intracellular Ca2+ concentration after 60 to 8...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50532608(CHEMBL4525688)
Affinity DataIC50: 2.70nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as reduction of rise in intracellular Ca2+ concentration after 60 to 8...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50532610(CHEMBL4451083)
Affinity DataIC50: 5.30nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50532610(CHEMBL4451083)
Affinity DataIC50: 5.30nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM698777(US20240317755, Compound L002)
Affinity DataIC50: 6.52nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM698778(US20240317755, Compound L007)
Affinity DataIC50: 7.37nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50532611(CHEMBL4562137)
Affinity DataIC50: 8.40nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50532611(CHEMBL4562137)
Affinity DataIC50: 8.40nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50532609(CHEMBL4466158)
Affinity DataIC50: 9nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50532609(CHEMBL4466158)
Affinity DataIC50: 9nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50519473(CHEMBL4546097)
Affinity DataIC50: 9.30nMAssay Description:Inhibition of human TRPC5 expressed in human T-REx-293 cells assessed as reduction in calcium influx by Fluo-4AM dye based assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM698776(US20240317755, Compound L001)
Affinity DataIC50: 10.8nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM698782(US20240317755, Compound L015)
Affinity DataIC50: 11.5nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50599832(CHEMBL5201831)
Affinity DataIC50: 14nMAssay Description:Inhibition of human TRPC5 channel expressed in HEK293 cells assessed as inhibition of EA-evoked channel current measured at +80 mV by whole-cell volt...More data for this Ligand-Target Pair
In DepthDetails
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM698780(US20240317755, Compound L013)
Affinity DataIC50: 14.6nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM246464(US9447114, 25)
Affinity DataIC50: 15.7nMpH: 7.2Assay Description:TRPC5 cells were induced 20-48 hours, removed from growth plates, and replated at low density (to attain good single-cell physical separation) on gla...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM698781(US20240317755, Compound L014)
Affinity DataIC50: 18.2nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM246453(US9447114, 13)
Affinity DataIC50: 21nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50532613(CHEMBL4464289)
Affinity DataIC50: 23nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50532613(CHEMBL4464289)
Affinity DataIC50: 23nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as blocking of inward/outward currents after 20 to 48 hrs in presence ...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM698783(US20240317755, Compound L019)
Affinity DataIC50: 24nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM246449(US9447114, 5)
Affinity DataIC50: 27nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM246450(US9447114, 6)
Affinity DataIC50: 27nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM246456(US9447114, 16)
Affinity DataIC50: 27nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM246458(US9447114, 18)
Affinity DataIC50: 27nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM246462(US9447114, 23)
Affinity DataIC50: 27nMpH: 7.4 T: 2°CAssay Description:The commercially available HEK293/TREx line (Invitrogen) was stably transfected with a TRPC5 construct and screened by conventional calcium imaging t...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50532613(CHEMBL4464289)
Affinity DataIC50: 27nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as reduction of rise in intracellular Ca2+ concentration after 60 to 8...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50532613(CHEMBL4464289)
Affinity DataIC50: 27nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as reduction of rise in intracellular Ca2+ concentration after 60 to 8...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50532610(CHEMBL4451083)
Affinity DataIC50: 31nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as reduction of rise in intracellular Ca2+ concentration after 60 to 8...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetShort transient receptor potential channel 5(Human)
National Cancer Institute

Curated by ChEMBL
LigandPNGBDBM50532610(CHEMBL4451083)
Affinity DataIC50: 31nMAssay Description:Inhibition of TRPC5 (unknown origin) transfected in HEK293/TREx cells assessed as reduction of rise in intracellular Ca2+ concentration after 60 to 8...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Displayed 1 to 50 (of 212 total ) | Next | Last >>
Jump to: